Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FIMMU.2023.1310262 | ||||
| Año | 2023 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Classically, particle-induced periprosthetic osteolysis at the implant-bone interface has explained the aseptic loosening of joint replacement. This response is preceded by triggering both the innate and acquired immune response with subsequent activation of osteoclasts, the bone-resorbing cells. Although particle-induced periprosthetic osteolysis has been considered a foreign body chronic inflammation mediated by myelomonocytic-derived cells, current reports describe wide heterogeneous inflammatory cells infiltrating the periprosthetic tissues. This review aims to discuss the role of those non-myelomonocytic cells in periprosthetic tissues exposed to wear particles by showing original data. Specifically, we discuss the role of T cells (CD3+, CD4+, and CD8+) and B cells (CD20+) coexisting with CD68+/TRAP- multinucleated giant cells associated with both polyethylene and metallic particles infiltrating retrieved periprosthetic membranes. This review contributes valuable insight to support the complex cell and molecular mechanisms behind the aseptic loosening theories of orthopedic implants.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Panez-Toro, Isidora | - |
Universidad de Chile - Chile
Nantes Univ - Francia Inst Cancerol Ouest - Francia Nantes Université - Francia Tumor Heterogeneity and Precision Medicine Laboratory - Francia |
| 2 | Heymann, Dominique | - |
Nantes Univ - Francia
Inst Cancerol Ouest - Francia UNIV SHEFFIELD - Reino Unido Nantes Université - Francia Tumor Heterogeneity and Precision Medicine Laboratory - Francia The University of Sheffield - Reino Unido |
| 3 | Gouin, Francois | - |
Ctr Leon Berard - Francia
Le Centre Régional de Lutte Contre le Cancer Léon Bérard - Francia |
| 4 | Amiaud, Jerome | - |
Nantes Univ - Francia
Nantes Université - Francia |
| 5 | Heymann, Marie Françoise | - |
Nantes Univ - Francia
Inst Cancerol Ouest - Francia Nantes Université - Francia Tumor Heterogeneity and Precision Medicine Laboratory - Francia |
| 6 | Córdova, Luis A.w. | Hombre |
Universidad de Chile - Chile
Ctr Intervent Med Precis & Adv Cellular Therapy - Chile CLIN DAVILA - Chile IMPACT - Chile Clinica Meds, Chile - Chile |
| Fuente |
|---|
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| Agencia Nacional de Investigación y Desarrollo |
| Conseil Régional des Pays de la Loire |
| Agencia Nacional de Investigacin y Desarrollo |
| Basal funding for Scientific and Technological Center of Excellence |
| IMPACT |
| Region des Pays de la Loire (France) |
| Agencia Nacional de Investigacion y Desarrollo (ANID) of Chile grants |
| Institut of Cancerologie de l'Ouest (Saint-Herblain, France) |
| Institut of Cancérologie de l’Ouest |
| Agradecimiento |
|---|
| The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was financially supported by Agencia Nacional de Investigacion y Desarrollo (ANID) of Chile grants: Fondecyt Inicio No 11190536 - Basal funding for Scientific and Technological Center of Excellence, IMPACT, #FB210024. IP-T is supported by the Region des Pays de la Loire (France) and the Institut of Cancerologie de l'Ouest (Saint-Herblain, France). |
| The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was financially supported by Agencia Nacional de Investigación y Desarrollo (ANID) of Chile grants: Fondecyt Inicio N°11190536 - Basal funding for Scientific and Technological Center of Excellence, IMPACT, #FB210024. IP-T is supported by the Region des Pays de la Loire (France) and the Institut of Cancérologie de l’Ouest (Saint-Herblain, France). |